Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Cigliano A, Zhang S, Ribback S, Steinmann S, Sini M, Ament CE, Utpatel K, Song X, Wang J, Pilo MG, Berger F, Wang H, Tao J, Li X, Pes GM, Mancarella S, Giannelli G, Dombrowski F, Evert M, Calvisi DF, Chen X, Evert K.
Cigliano A, et al. Among authors: zhang s.
J Exp Clin Cancer Res. 2023 May 17;42(1):124. doi: 10.1186/s13046-023-02709-x.
J Exp Clin Cancer Res. 2023.
PMID: 37194029
Free PMC article.
No abstract available.